SLSN
SLSN
NASDAQ · Chemicals

Solesence Inc

$1.08
+0.13 (+13.85%)
As of Apr 1, 3:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
59.86M
Net Income
4.84M
Gross Margin
30.9%
Profit Margin
8.1%
Rev Growth
+21.1%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 30.9% 30.9% 44.0% 44.0%
Operating Margin 9.8% 8.8% 20.4% 16.3%
Profit Margin 8.1% 7.7% 13.0% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 59.86M 49.43M 30.11M 28.35M
Gross Profit 18.51M 15.28M 13.23M 12.46M
Operating Income 5.87M 4.36M 6.14M 4.63M
Net Income 4.84M 3.60M 3.91M 4.44M
Gross Margin 30.9% 30.9% 44.0% 44.0%
Operating Margin 9.8% 8.8% 20.4% 16.3%
Profit Margin 8.1% 7.7% 13.0% 15.7%
Rev Growth +21.1% +21.1% +8.3% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 8.28M 8.28M 14.89M 14.06M
Total Equity 24.74M 24.74M 59.27M 54.81M
D/E Ratio 0.33 0.33 0.25 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 6.93M 5.44M 7.35M 6.83M
Free Cash Flow 3.76M 3.68M